Diabetes Clinical Trials in Seattle

Showing 241-260 of 375 trials

Diet and Metabolic Inflammation

NCT02539355

Obesity is a risk factor for several common cancers, including those of the breast, colon, liver, and pancreas. Proposed molecular links between obesity and these types of cancer include systemic inflammation, hyperinsulinemia, and changes in the serum concentrations of sex steroid hormones and adipokines. All of these are strongly linked to low-grade chronic inflammatory processes in expanded adipose tissue. The objective of this proposal is to test the hypothesis that adipose tissue inflammation can be reduced by the foods we eat.

Insulin ResistanceDiabetesCancer+2 more

Fred Hutchinson Cancer Center16 participantsStarted Aug 2015

Seattle, Washington, United States

COMPLETEDPhase 310 miles

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

NCT02100475

This trial is conducted globally. The aim of the trial is to compare sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensification. This is an extension to trial NN9068-3952, NCT01952145 (DUAL™ V).

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S31 participantsStarted Apr 2014

Fresno, California, United States • Fort Lauderdale, Florida, United States • Gurnee, Illinois, United States +57 more locations

Diet and Metabolic Inflammation

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Diabetes Trials in Other Cities

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

Adult Accuracy Study of the Enlite 3 Glucose Sensor

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

Other Conditions in Seattle